Author
Dean Kavanagh
Also Known As
D Kavanagh, D P J Kavanagh, D P Kavanagh, D. Kavanagh, Dean Kavanagh, Dean P J Kavanagh, Dean P. J. Kavanagh, Dean P. Kavanagh, Dean P.J. Kavanagh, Dean Philip John Kavanagh
70
Publications
1.2K
Citations
16
H-Index
34
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 4 | 4 | 197 |
2 | Cell Biology | 3 | 3 | 141 |
3 | Health Sciences | 1 | 1 | 18 |
4 | Cellular Physiology | 1 | 1 | 18 |
5 | Cellular Therapies | 1 | 1 | 39 |
Dean Kavanagh
×
16
Publications
999
Citations
15
H-Index
| Year | Citations | |
|---|---|---|
2012 | 198 | |
2006 | 173 | |
2019 | 87 | |
2010 | 84 | |
2021 | 76 | |
2012 | 67 | |
2017 | 63 | |
The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-δ dependent manner Peter Hampson, Dean Kavanagh, Emily Smith, Cancer Immunology Immunotherapy InflammationTumor BiologyAnti-inflammatoryCytotoxic NeutrophilsPkc-δ Dependent Manner | 2008 | 56 |
2015 | 39 | |
2009 | 34 |
Page 1
Page 1